Search

Bernard R Neustadt

from West Orange, NJ
Age ~81
Get Report
Also known as:
Bernard Neustabt, Barry R Neustadt, Barry S Neustadt, Boruch S Neustadt, Burry S Neustadt, Bernard T
Phone and address:
24 Brook Pl, Town Center, NJ 07052
(973) 715-7402
Related to:
Avrohom D Schechter, 53Steven A Schachter, 41Aviella NeustadtEfriam Sinowitz, 50Helen L Neustadt, 79Michal Sinowitz, 53Rizka SinowitzJonah G Sinowitz, 53Drmelvin SinowitzJeffrey N Shapiro, 51Aviella Neustadt, 56Rebecca Sinowitz, 47Judith B Shapiro, 52
Connected to:
Carman G Neustaedter, 45Gabriel G Neustadt, 34James A Neustaedter, 104John T Neustadter, 72Tanja Neustadt, 54Tarl Neustaedter, 65Tatiana C Neustadter, 34Paul L Neustedter, 56Angela G Neustifter, 60Lauren J Neuteboom, 38

Bernard Neustadt Phones & Addresses

  • 24 Brook Pl, West Orange, NJ 07052 (973) 715-7402
  • Orange, NJ
  • 24 Brook Pl, West Orange, NJ 07052

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Brandeis University 1966 to 1969 Specialities: Organic Chemistry

Skills

Nmr • Pharmaceutical Patents • Organic Chemistry • Lead Change • Synthetic Organic Chemistry • Organic Synthesis • Heterocyclic Chemistry • Medicinal Chemistry • Drug Discovery

Languages

German • Russian

Industries

Pharmaceuticals

Resumes

Resumes

Bernard Neustadt Photo 1

Bernard Neustadt

View page
Location:
24 Brook Pl, West Orange, NJ 07052
Industry:
Pharmaceuticals
Education:
Brandeis University 1966 - 1969
Doctorates, Doctor of Philosophy, Organic Chemistry Columbia University In the City of New York 1960 - 1964
Bachelors, Bachelor of Arts, Chemistry
Skills:
Nmr
Pharmaceutical Patents
Organic Chemistry
Lead Change
Synthetic Organic Chemistry
Organic Synthesis
Heterocyclic Chemistry
Medicinal Chemistry
Drug Discovery
Languages:
German
Russian

Publications

Us Patents

Piperidine Derivatives Useful As Ccr5 Antagonists

View page
US Patent:
6387930, May 14, 2002
Filed:
May 1, 2000
Appl. No.:
09/562815
Inventors:
Bahige M. Baroudy - Westfield NJ
John W. Clader - Cranford NJ
Hubert B. Josien - Jersey City NJ
Stuart W. McCombie - Caldwell NJ
Brian A. McKittrick - Bloomfield NJ
Michael W. Miller - Westfield NJ
Bernard R. Neustadt - West Orange NJ
Anandan Palani - Kenilworth NJ
Ruo Steensma - Weehawken NJ
Jayaram R. Tagat - Westfield NJ
Susan F. Vice - Mountainside NJ
Mark A. Laughlin - Edison NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07D40104
US Classification:
514316, 546186, 546187, 546188, 546191, 544242, 544336
Abstract:
The use of CCR5 antagonists of the formula or a pharmaceutically acceptable salt thereof, wherein X is âC(R ) â, âC(R )(R )â, âC(O)â, âOâ, âNHâ, âN(alkyl)â, R is optionally substituted phenyl, pyridyl, thiophenyl or naphthyl; R is H, alkyl or alkenyl; R is optionally substituted phenyl, phenylalkyl, heteroaryl or heteroarylalkyl, naphthyl, fluorenyl or diphenylmethyl; R is optionally substituted phenyl, heteroaryl or naphthyl; R is H, alkyl, fluoro-alkyl, cyclopropylmethyl, âCH CH OH, âCH CH âO-alkyl, âCH C(O)âO-alkyl, âCH C(O)NH , âCH C(O)âNHalkyl or âCH C(O)âN(alkyl) ; R is optionally substituted phenyl, heteroaryl or naphthyl, cycloalkyl, cycloalkylalkyl or alkoxyalkyl; and R , R , R , R and R are hydrogen or alkyl for the treatment of HIV, solid organ transplant rejection, graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis is disclosed, as well as novel compounds, pharmaceutical compositions comprising them, and the combination of CCR5 antagonists of the invention in combination with antiviral agents useful in the treatment of HIV or agents useful in the treatment of inflammatory diseases.

Piperazine Derivatives Useful As Ccr5 Antagonists

View page
US Patent:
6391865, May 21, 2002
Filed:
May 1, 2000
Appl. No.:
09/562814
Inventors:
Bahige M. Baroudy - Westfield NJ
John W. Clader - Cranford NJ
Hubert B. Josien - Jersey City NJ
Stuart W. McCombie - Caldwell NJ
Brian A. McKittrick - Bloomfield NJ
Michael W. Miller - Westfield NJ
Bernard R. Neustadt - West Orange NJ
Anandan Palani - Kenilworth NJ
Elizabeth M. Smith - Verona NJ
Ruo Steensma - Weehawken NJ
Jayaram R. Tagat - Westfield NJ
Susan F. Vice - Mountainside NJ
Eric Gilbert - Scotch Plains NJ
Marc A. Labroli - Mount Laurel NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A01N 5500
US Classification:
514 63, 514 64, 51425211, 51425218, 51425301, 5142531, 51425311, 51425309, 544229, 544295, 544360, 544364
Abstract:
The use of CCR5 antagonists of the formula or a pharmaceutically acceptable salt thereof, wherein R is optionally substituted phenyl, pyridyl, thiophenyl or naphthyl; R is hydrogen or alkyl; R is substituted phenyl, substituted heteroaryl, naphthyl, fluorenyl, diphenylmethyl or optionally substituted phenyl- or heteroaryl-alkyl; R is hydrogen, alkyl, alkoxyalkyl, cycloalkyl, cycloalkylalkyl, or optionally substituted phenyl, phenylalkyl, naphthyl, naphthylalkyl, heteroaryl or heteroarylalkyl; R , R and R are hydrogen or alkyl; R is hydrogen, alkyl or alkenyl; for the treatment of HIV, solid organ transplant rejection, graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis is disclosed, as well as novel compounds, pharmaceutical compositions comprising them, and the combination of CCR5 antagonists of the invention in combination with antiviral agents useful in the treatment of HIV or agents useful in the treatment of inflammatory diseases.

Piperidine Derivatives Useful As Ccr5 Antagonists

View page
US Patent:
6602885, Aug 5, 2003
Filed:
Nov 8, 2001
Appl. No.:
10/010481
Inventors:
Bahige M. Baroudy - Westfield NJ
John W. Clader - Cranford NJ
Hubert B. Josien - Jersey City NJ
Stuart W. McCombie - Caldwell NJ
Brian A. McKittrick - Bloomfield NJ
Michael W. Miller - Westfield NJ
Bernard R. Neustadt - West Orange NJ
Anandan Palani - Kenilworth NJ
Ruo Steensma - Weehawken NJ
Jayaram R. Tagat - Westfield NJ
Susan F. Vice - Mountainside NJ
Mark A. Laughlin - Edison NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 314545
US Classification:
514316, 546186, 546187, 546188, 546191, 544542, 544336
Abstract:
The use of CCR5 antagonists of the formula or a pharmaceutically acceptable salt thereof, wherein R is optionally substituted phenyl, pyridyl, thiophenyl or naphthyl; R is H, alkyl or alkenyl; R is optionally substituted phenyl, phenylalkyl, heteroaryl or heteroarylalkyl, naphthyl, fluorenyl or diphenylmethyl; R is optionally substituted phenyl, heteroaryl or naphthyl; R is H, alkyl, fluoro-alkyl, cyclopropylmethyl, âCH CH OH, âCH CH âO-alkyl, âCH C(O)âO-alkyl, âCH C(O)NH , âCH C(O)âNHalkyl or âCH C(O)âN(alkyl) ; R is optionally substituted phenyl, heteroaryl or naphthyl, cycloalkyl, cycloalkylalkyl or alkoxyalkyl; and R , R , R , R and R are hydrogen or alkyl for the treatment of HIV, solid organ transplant rejection, graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis is disclosed, as well as novel compounds, pharmaceutical compositions comprising them, and the combination of CCR5 antagonists of the invention in combination with antiviral agents useful in the treatment of HIV or agents useful in the treatment of inflammatory diseases.

Adenosine A2A Receptor Antagonists

View page
US Patent:
6630475, Oct 7, 2003
Filed:
May 24, 2001
Appl. No.:
09/865071
Inventors:
Bernard R. Neustadt - West Orange NJ
Neil Lindo - New Providence NJ
William J. Greenlee - Teaneck NJ
Deen Tulshian - Lebanon NJ
Lisa S. Silverman - Edison NJ
Yan Xia - Edison NJ
Craig D. Boyle - Branchburg NJ
Samuel Chackalamannil - East Brunswick NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07D40314
US Classification:
514257, 51425505, 51425216, 51425211, 51425202, 5142332, 5142285, 514218, 51421706, 51421115, 51421108, 540601, 540575, 540553, 540470, 540480, 540466, 540513, 54021202, 544115, 544238, 544251, 544230, 544 61
Abstract:
Compounds having the structural formula I or a pharmaceutically acceptable salt thereof, wherein R is optionally substituted phenyl, cycloalkenyl, or heteroaryl; X is alkylene or âC(O)CH â; Y is âN(R )CH CH N(R) )â, âOCH CH N(R )â, âOâ, âSâ, âCH Sâ, â(CH ) âNHâ, or optionally substituted âm and n are 2-3, and Q is nitrogen or optionally substituted carbon; and Z is optionally substituted phenyl, phenylalkyl or heteroaryl, diphenylmethyl, R âC(O)â, R âSO â, R âOC(O)â, R âN(R )âC(O)â, R âN(R )âC(S)â, âphenyl-CH(OH)â, or phenyl-C( NOR )â; or when Q is CH, phenylamino or pyridylamino; or Z and Y together are substituted piperidinyl or substituted phenyl; and R , R , R , R , and R are as defined in the specification are disclosed, their use in the treatment of Parkinsons disease, alone or in combination with other agents for treating Parkinsons disease, and pharmaceutical compositions comprising them; also disclosed are a processes for preparing intermediates useful for preparing compounds of formula I.

Piperazine Derivatives Useful As Ccr5 Antagonists

View page
US Patent:
6689765, Feb 10, 2004
Filed:
Jan 30, 2002
Appl. No.:
10/061011
Inventors:
Bahige M. Baroudy - Westfield NJ
John W. Clader - Cranford NJ
Hubert B. Josien - Jersey City NJ
Stuart W. McCombie - Caldwell NJ
Brian A. McKittrick - Bloomfield NJ
Michael W. Miller - Westfield NJ
Bernard R. Neustadt - West Orange NJ
Anandan Palani - Kenilworth NJ
Elizabeth M. Smith - Verona NJ
Ruo Steensma - Weehawken NJ
Jayaram R. Tagat - Westfield NJ
Susan F. Vice - Mountainside NJ
Mark A. Laughlin - Edison NJ
Eric Gilbert - Scotch Plains NJ
Marc A. Labroli - Mount Laurel NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 31695
US Classification:
514 63, 514 64, 51425212, 51425213, 51425219, 51425301, 5142531, 51425311, 514 2, 514 42, 514 43, 514 45, 514 49, 514220, 514262, 514263
Abstract:
The use of CCR5 antagonists of the formula or a pharmaceutically acceptable salt thereof, wherein R is optionally substituted phenyl, pyridyl, thiophenyl or naphthyl; R is hydrogen or alkyl; R is substituted phenyl, substituted heteroaryl, naphthyl, fluorenyl, diphenylmethyl or optionally substituted phenyl- or heteroaryl-alkyl; R is hydrogen, alkyl, alkoxyalkyl, cycloalkyl, cycloalkylalkyl, or optionally substituted phenyl, phenylalkyl, naphthyl, naphthylalkyl, heteroaryl or heteroarylalkyl; R , R and R are hydrogen or alkyl; R is hydrogen, alkyl or alkenyl; for the treatment of HIV, solid organ transplant rejection, graft v, host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis is disclosed, as well as novel compounds, pharmaceutical compositions comprising them, and the combination of CCR5 antagonists of the invention in combination with antiviral agents useful in the treatment of HIV or agents useful in the treatment of inflammatory diseases.

[1,2,4]-Triazole Bicyclic Adeonsine A2A Receptor Antagonists

View page
US Patent:
6875772, Apr 5, 2005
Filed:
Nov 26, 2002
Appl. No.:
10/304939
Inventors:
Bernard R. Neustadt - West Orange NJ, US
Hong Liu - Hackensack NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07D487/04
A61K031/519
A61P025/24
A61P025/16
US Classification:
5142621, 544263, 544295, 544324, 546117
Abstract:
Compounds having the structural formula I wherein:.

Adenosine A2A Receptor Antagonists

View page
US Patent:
6897216, May 24, 2005
Filed:
May 30, 2003
Appl. No.:
10/448854
Inventors:
Bernard R. Neustadt - West Orange NJ, US
Neil Lindo - New Providence NJ, US
William J. Greenlee - Teaneck NJ, US
Deen Tulshian - Lebanon NJ, US
Lisa S. Silverman - Edison NJ, US
Yan Xia - Edison NJ, US
Craig D. Boyle - Branchburg NJ, US
Samuel Chackalamannil - East Brunswick NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K031/519
US Classification:
514250, 51425216, 514257
Abstract:
Compounds having the structural formula I or a pharmaceutically acceptable salt thereof, wherein.

2-Alkynyl-And 2-Alkenyl-Pyrazolo-[4,3-E]-1,2,4-Triazolo-[1,5-C]-Pyrimidine Adenosine A2A Receptor Antagonists

View page
US Patent:
6897217, May 24, 2005
Filed:
Apr 21, 2004
Appl. No.:
10/829416
Inventors:
Bernard R. Neustadt - West Orange NJ, US
Jinsong Hao - Belle Mead NJ, US
Hong Liu - Hackensack NJ, US
Craig D. Boyle - Branchburg NJ, US
Samuel Chackalamannil - Califon NJ, US
Unmesh G. Shah - Scotch Plains NJ, US
Andrew Stamford - Chatham Township NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07D403/06
A61K031/497
US Classification:
51425216, 514267, 544251
Abstract:
Compounds having the structural formula I or a pharmaceutically acceptable salt thereof, wherein.
Control profile
Bernard R Neustadt from West Orange, NJ, age ~81 Get Report